Literature DB >> 23543378

Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies.

Hai Cun Shi1, Jian Guo Zhong, Ping Lei Pan, Pei Rong Xiao, Yuan Shen, Li Juan Wu, Hua Liang Li, Yuan Ying Song, Gui Xiang He, Hong Ye Li.   

Abstract

Voxel-based morphometry (VBM) studies have provided cumulative evidence of gray matter (GM) atrophy in patients with progressive supranuclear palsy (PSP) relative to healthy controls (HC). However, not all findings have been entirely concordant. Herein, we performed a quantitative meta-analysis study in order to consistently quantify GM anomalies in PSP. We conducted a systematic search for VBM studies of PSP patients and HC using PubMed and Embase databases from January 2000 to May 2012. Meta-analysis of these VBM studies was performed using a newly improved voxel-based meta-analytic technique, effect-size signed differential mapping. A total of 9 cross-sectional VBM studies that involved 143 PSP patients and 216 HC subjects met the inclusion criteria. Considerable regional GM volume decrease was detected in the thalamus, basal ganglia, midbrain, insular cortex, and frontal cortex. These findings remained largely unchanged following jackknife sensitivity analyses. The present meta-analysis provided evidence of PSP-specific GM atrophy. This finding might help contribute to our understanding of the neurobiological basis underlying PSP.

Entities:  

Mesh:

Year:  2013        PMID: 23543378     DOI: 10.1007/s10072-013-1406-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  50 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

3.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

4.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.

Authors:  A Padovani; B Borroni; S M Brambati; C Agosti; M Broli; R Alonso; P Scifo; G Bellelli; A Alberici; R Gasparotti; D Perani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

5.  Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.

Authors:  Demetrio Messina; Antonio Cerasa; Francesca Condino; Gennarina Arabia; Fabiana Novellino; Giuseppe Nicoletti; Maria Salsone; Maurizio Morelli; Pier Luigi Lanza; Aldo Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2011-01-13       Impact factor: 4.891

6.  Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy.

Authors:  H Hanyu; T Asano; H Sakurai; M Takasaki; H Shindo; K Abe
Journal:  Neuroradiology       Date:  2001-07       Impact factor: 2.804

7.  Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder?

Authors:  Esther Via; Joaquim Radua; Narcis Cardoner; Francesca Happé; David Mataix-Cols
Journal:  Arch Gen Psychiatry       Date:  2011-04

8.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Authors:  Adam L Boxer; Michael D Geschwind; Nataliya Belfor; Maria Luisa Gorno-Tempini; Guido F Schauer; Bruce L Miller; Michael W Weiner; Howard J Rosen
Journal:  Arch Neurol       Date:  2006-01

9.  Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.

Authors:  Karin Srulijes; Matthias Reimold; Rajka M Liscic; Sarah Bauer; Elisabeth Dietzel; Inga Liepelt-Scarfone; Daniela Berg; Walter Maetzler
Journal:  Mov Disord       Date:  2012-01       Impact factor: 10.338

10.  Progressive supranuclear palsy: a survey of the disease course.

Authors:  P Santacruz; B Uttl; I Litvan; J Grafman
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  13 in total

Review 1.  Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.

Authors:  Keita Sakurai; Aya M Tokumaru; Keigo Shimoji; Shigeo Murayama; Kazutomi Kanemaru; Satoru Morimoto; Ikuko Aiba; Motoo Nakagawa; Yoshiyuki Ozawa; Masashi Shimohira; Noriyuki Matsukawa; Yoshio Hashizume; Yuta Shibamoto
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

2.  Sleep Disorders in Atypical Parkinsonism.

Authors:  Sabra M Abbott; Aleksandar Videnovic
Journal:  Mov Disord Clin Pract       Date:  2014-06-01

3.  MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Neeraj Upadhyay; Antonio Suppa; Maria Cristina Piattella; Matteo Bologna; Flavio Di Stasio; Alessandra Formica; Francesca Tona; Carlo Colosimo; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2016-07-13       Impact factor: 4.849

Review 4.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

5.  Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease.

Authors:  Roxana G Burciu; Edward Ofori; Priyank Shukla; Peggy J Planetta; Amy F Snyder; Hong Li; Chris J Hass; Michael S Okun; Nikolaus R McFarland; David E Vaillancourt
Journal:  Mov Disord       Date:  2015-07-06       Impact factor: 10.338

6.  Disrupted resting-state functional connectivity in progressive supranuclear palsy.

Authors:  M C Piattella; F Tona; M Bologna; E Sbardella; A Formica; N Petsas; N Filippini; A Berardelli; P Pantano
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-05       Impact factor: 3.825

Review 7.  The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

8.  Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study.

Authors:  Karsten Mueller; Robert Jech; Cecilia Bonnet; Jaroslav Tintěra; Jaromir Hanuška; Harald E Möller; Klaus Fassbender; Albert Ludolph; Jan Kassubek; Markus Otto; Evžen Růžička; Matthias L Schroeter
Journal:  Front Neurosci       Date:  2017-03-07       Impact factor: 4.677

9.  Quantitative T1 and T2 MRI signal characteristics in the human brain: different patterns of MR contrasts in normal ageing.

Authors:  Michael J Knight; Bryony McCann; Demitra Tsivos; Elizabeth Couthard; Risto A Kauppinen
Journal:  MAGMA       Date:  2016-06-22       Impact factor: 2.310

10.  Repeatability of Brain Volume Measurements Made with the Atlas-based Method from T1-weighted Images Acquired Using a 0.4 Tesla Low Field MR Scanner.

Authors:  Masami Goto; Makoto Suzuki; Shinya Mizukami; Osamu Abe; Shigeki Aoki; Tosiaki Miyati; Michinari Fukuda; Tsutomu Gomi; Tohoru Takeda
Journal:  Magn Reson Med Sci       Date:  2016-02-03       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.